Literature DB >> 8598473

IL-3 augments TCR-mediated responses of type 2 CD4 T cells.

Y Dan1, Y Katakura, A Ametani, S Kaminogawa, Y Asano.   

Abstract

A subset of type 2, but not type 1, CD4 T cell clones expresses IL-3R and can be stimulated by IL-3. Expression of IL-3R on these type 2 T cell clones is induced by TCR stimulation, and subsequent stimulation by IL-3 augmented the proliferation of and IL-4 production by these cells. This augmented response is inhibited by anti-IL-4 mAb, suggesting the involvement of IL-4 in this response. In place of TCR stimulation, treatment of these type 2 CD4 T cell clones with PMA rendered them responsive to further stimulation of proliferation by IL-3, indicating the cooperation between the IL-3R-elicited signals and PKC-mediated signals in stimulating proliferation. Although the augmentation of the TCR-mediated proliferative response by IL-3 was mainly due to the increased production of IL-4, we also demonstrated the presence of IL-4-independent mechanism mediating the response to IL-3. In situ, we found that splenic T cells could be induced to respond to Il-3 by TCR stimulation. Thus, IL-3 can stimulate a specific population of T cells and influence the immune response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8598473

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

Review 1.  Crossing paths: interactions between the cell death machinery and growth factor survival signals.

Authors:  Gabriela Brumatti; Marika Salmanidis; Paul G Ekert
Journal:  Cell Mol Life Sci       Date:  2010-02-16       Impact factor: 9.261

2.  Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells.

Authors:  Donatella Aldinucci; Dalisa Poletto; Annunziata Gloghini; Paola Nanni; Massimo Degan; Tiziana Perin; Paola Ceolin; Francesca Maria Rossi; Valter Gattei; Antonino Carbone; Antonio Pinto
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.